CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The updated guideline addresses rapid advances in pharmacologic management, balancing use of newer, older drugs.

Scientists have discovered an answer to the longstanding mystery of why more than half of patients with chronic kidney ...

Jennifer Green, MD, provides considerations for the use of SGLT2 inhibitors in treatment of CKD. Ryan Haumschild, PharmD, MS, MBA: As we talk about SGLT2s [sodium-glucose cotransporter-2 inhibitors] ...

Scientists have uncovered why people with chronic kidney disease so often die from heart problems: damaged kidneys release ...

"People with chronic kidney disease generally have no symptoms until they’re very near kidney failure," said kidney-health ...

Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm. Kidney disease is a serious yet often overlooked condition that affects millions ...

Scientists have discovered an answer to the longstanding mystery of why more than half of patients with chronic kidney ...

Kidney disease is a serious yet often overlooked condition that affects millions worldwide. Despite its impact, it is frequently underestimated compared to illnesses like cancer and heart disease. The ...